Quarterly report pursuant to Section 13 or 15(d)

Consolidated Interim Consolidated Balance Sheets

v3.10.0.1
Consolidated Interim Consolidated Balance Sheets - USD ($)
Aug. 31, 2018
Nov. 30, 2017
CURRENT    
Cash and cash equivalents $ 473,901 $ 1,965,043
Accounts receivable 33,380 36,412
Inventory 159,738 157,303
Prepaid expenses and other receivables 103,451 6,648
Total Current Assets 770,470 2,165,406
Patents 108,167 0
Deposit for equipment 180,000 0
Property and equipment 113,162 26,951
TOTAL ASSETS 1,171,799 2,192,357
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 296,348 393,341
Unsecured convertible debentures 0 40,357
Secured convertible debentures 966,406 0
Derivative liabilities 290,382 539,860
Total Current Liabilities 1,553,136 973,558
Long term secured convertible debentures 0 892,176
Total Liabilities 1,553,136 1,865,734
Capital stock    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (November 30, 2017 - nil). 0 0
Common stock, $0.001 par value 200,000,000 shares authorized (2017: 200,000,000), 94,494,088 issued and outstanding (November 30, 2017: 93,014,134) 94,494 93,014
Additional paid-in capital 31,621,504 31,365,097
Deficiency (32,057,536) (31,098,864)
Accumulated Other Comprehensive Loss (39,799) (32,624)
Total Stockholders' (Deficiency) Equity (381,337) 326,623
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIENCY) EQUITY $ 1,171,799 $ 2,192,357